Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estudio clínico, Aleatorizado, Doble Ciego, Paralelo, Controlado Con Gel de ácido láctico Para Evaluar la Eficacia Del Gel Papilocare® en la reparación de Lesiones Cervicales Causadas Por VPH. A Randomized, Double-blind, Parallel-group, Controlled Clinical Trial Using Lactic Acid Gel to Evaluate the Efficacy of Papilocare® Gel in Repairing Cervical Lesions Caused by HPV.

NCT04210336 is registered in ClinicalTrials.gov with Procare Health Iberia S.L. as lead sponsor.

NCT NCT04210336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04210336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estudio clínico, Aleatorizado, Doble Ciego, Paralelo, Controlado Con Gel de ácido láctico Para Evaluar la Eficacia Del Gel Papilocare® en la reparación de Lesiones Cervicales Causadas Por VPH. A Randomized, Double-blind, Parallel-group, Controlled Clinical Trial Using Lactic Acid Gel to Evaluate the Efficacy of Papilocare® Gel in Repairing Cervical Lesions Caused by HPV.
Lead sponsor
Procare Health Iberia S.L.
Phase
Not applicable
Overall status
Completed
Start date
August 7, 2018
Completion date
January 20, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, lesion cervix